Drug class
Recombinant coagulation factor VIII; antihaemorrhagic biologic
Mechanism of action
Replaces deficient factor VIII in the intrinsic coagulation pathway. Activated factor VIII acts as a cofactor for activated factor IX, accelerating factor X activation and subsequent thrombin and fibrin clot formation.
General use cases
- Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency), including perioperative management, under the authorised product indication.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
